Sage Journals: Discover world-class research

Open access

Research article

First published 2025

Major adverse cardiovascular events or venous thromboembolism in patients with rheumatoid arthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a nationwide,population-based cohort study

Chung-Mao Kao, Yen-Ju Chen, Yi-Ming Chen [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2022

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis

Marta Novella-Navarro, Diego Benavent, Virginia Ruiz-Esquide [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2020

Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage

Julien Blaess, Julia Walther, Arthur Petitdemange [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2024

Monotherapy or combination therapy in PsA: current aspects

Elpida Skouvaklidou, Paraskevi Avgerou, Konstantinos D. Vassilakis [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Letter

First published 2023-12

Comparison of COVID-19 Vaccination and Infection Rates in Adult Patients With Autoimmune Inflammatory Disease on b/tsDMARD Therapy

Viktoriya Avlasevich, Katharine McCarthy

Annals of Pharmacotherapy

Open access

Research article

First published 2022

Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry

Jung Hee Koh, Yusun Lee, Hyoun-Ah Kim [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2024

Switching related to inefficacy in biologics and targeted synthetic therapies for psoriatic arthritis: a comparative real-life study

Dalifer Freites-Nuñez, Leticia Leon, Esther Toledano [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2020

Tuberculosis and targeted synthetic or biologic DMARDs,beyond tumor necrosis factor inhibitors

Gerasimos Evangelatos, Vasiliki Koulouri, Alexios Iliopoulos [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Review article

First published 2022

Is there still a place for methotrexate in severe psoriatic arthritis?

Renaud Felten, Grégoire Lambert De Cursay, Eric Lespessailles

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2024

Risk factors for interstitial lung disease in rheumatoid arthritis: a cohort study from the KOBIO registry

Hong Ki Min, Se Hee Kim, Sang-Heon Lee [...]

Therapeutic Advances in Musculoskeletal Disease

Search results